Percutaneous Mechanical Support for the Failing Right Heart

Cardiology Clinics

Volumn 30, Issue 2, 2012, Pages 303-310

  Goldstein, James A ^a   Kern, Morton J ^b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

Inferior myocardial infarction; Percutaneous mechanical support; Right heart failure; Ventricular assist device

Indexed keywords

INOTROPIC AGENT; VASODILATOR AGENT;

ACUTE DISEASE; ACUTE HEART INFARCTION; AORTA BALLOON; BIVENTRICULAR ASSIST DEVICE; BLALOCK HANLON OPERATION; CARDIOVASCULAR PROCEDURE; COUNTERPULSATION; DISEASE SEVERITY; HEART ASSIST DEVICE; HEART ELECTROPHYSIOLOGY; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART PRELOAD; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART SURGERY; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LUNG EMBOLISM; PERCUTANEOUS ASSIST DEVICE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RIGHT VENTRICULAR ASSIST DEVICE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBECTOMY;

ACUTE DISEASE; BLOOD VESSEL PROSTHESIS IMPLANTATION; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; HYPERTENSION, PULMONARY; PROSTHESIS DESIGN; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84860378371     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2012.03.007     Document Type: Review

References (30)

1. Goldstein J.A. State of the art review: pathophysiology and management of right heart ischemia. J Am Coll Cardiol 2002, 40:841-853.
2. Bowers T.R., O'Neill W.W., Grines C., et al. Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med 1998, 338:933-940.
3. Atiemo A.D., Conte J.V., Heldman A.W. Resuscitation and recovery from acute right ventricular failure using a percutaneous right ventricular assist device. Catheter Cardiovasc Interv 2006, 66:78-82.
4. Giesler G.M., Gomez J.S., Letsou G., et al. Initial report of percutaneous right ventricular assist for right ventricular shock secondary to right ventricular infarction. Catheter Cardiovasc Interv 2006, 68:263-266.
5. Meyer P., Gerasimos F.S., Ahmed M.I., et al. Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure. Circulation 2010, 121:252-258.
6. Banerjee D., Haddad F., Zamanian R.T., et al. Right ventricular failure: a novel era of targeted therapy. Curr Heart Fail Rep 2010, 7:202-211.
7. Fukamachi K., McCarthy P.M., Smedira N.G., et al. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg 1999, 68:2181-2184.
8. Taylor D.O., Edwards L.B., Aurora P., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report-2008. J Heart Lung Transplant 2008, 27(9):943-956.
9. Lee S., Kamdar F., Madlon-Kay R., et al. Effects of the HeartMate II continuous-flow left ventricular assist device on right ventricular function. Heart Lung Transplant 2010, 29:209-315.
10. Matthews J.C., Koelling T.M., Pagani F.D., et al. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 2008, 51(22):2163-2172.
11. Jett G.K., Picone A.L., Clark R.E. Circulatory support for right ventricular dysfunction. J Thorac Cardiovasc Surg 1987, 94(1):95-103.
12. Higgins R.S., Elefteriades J.A. Right ventricular assist devices and the surgical treatment of right ventricular failure. Cardiol Clin 1992, 10(1):185-192.
13. Reiss N., El-Banayosy A., Mirow N., et al. Implantation of the Biomedicus centrifugal pump in post-transplant right heart failure. J Cardiovasc Surg 2000, 41:691-694.
14. Moazami N., Pasque M.K., Moon M.R., et al. Mechanical support for isolated right ventricular failure in patients after cardiotomy. J Heart Lung Transplant 2004, 23(12):1371-1375.
15. Osaki S., Edwards N.M., Johnson M.R., et al. A novel use of the implantable ventricular assist device for isolated right heart failure. Interact Cardiovasc Thorac Surg 2008, 7:651-653.
16. Law M.A., Grifka R.G., Mullins C.E., et al. Atrial septostomy improves survival in select patients with pulmonary hypertension. Am Heart J 2007, 153:779-784.
17. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001, 345:1435-1443.
18. Kormos R.L., Teuteberg J.J., Pagani F.D., et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010, 139(5):1316-1324.
19. Miller L.W., Pagani F.D., Russell S.D., et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007, 357:9.
20. Hsu P.L., Parker J., Egger C., et al. Mechanical circulatory support for right heart failure, 2011 mechanical circulatory support for right heart failure: current technology and future outlook. Artif Organs 2011, 10.1111/j.1525-1594.2011.01366.x.
21. Shuhaiber J.H., Jenkins D., Berman M., et al. The Papworth experience with the LevitronixCentriMag ventricular assist device. J Heart Lung Transplant 2008, 27:158-164.
22. Anderson M., Smedira N., Samuels L., et al. Use of the AB5000 ventricular assist device in cardiogenic shock after acute myocardial infarction. Ann Thorac Surg 2010, 90(3):706-712.
23. Krabatsch T., Potapov E., Stepanenko A., et al. Biventricular circulatory support with two miniaturized implantable assist devices. Circulation 2011, 124(Suppl 1):S179-S186.
24. Naidu S.S. Novel percutaneous cardiac assist devices the science of and indications for hemodynamic support. Circulation 2011, 123:533-543.
25. Vranckx P., Meliga E., De Jaegere P.P., et al. The Tandem Heart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions: the six-year Rotterdam experience. EuroIntervention 2008, 4:331-337.
26. Thomas J.L., Al-Ameri H., Economides C., et al. Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock. J Invasive Cardiol 2010, 22:360-364.
27. Schwartz B.G., Ludeman D.J., Mayeda G.S., et al. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience. J Invasive Cardiol 2011, 23:417-424.
28. Kovacic J.C., Nguyen H.T., Karajgikar R., et al. The impella recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention. Catheter Cardiovasc Interv 2011, DOI: 10.1002/ccd.22929. [Epub ahead of print].
29. Maini B., Naidu S.S., Mulukutla S., et al. Real-world use of the impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the Uspella registry. Catheter Cardiovasc Interv 2011, DOI: 10.1002/ccd.23403. [Epub ahead of print].
30. Engström A.E., Sjauw K.D., Baan J., et al. Long-term safety and sustained left ventricular recovery: long-term results of percutaneous left ventricular support with Impella LP2.5 in ST-elevation myocardial infarction. EuroIntervention 2011, 6:860-865.